NDC 71335-0160 is a in the category. It is labeled and distributed by .
| Proprietary Name | NDC 71335-0160 |
| Marketing Category | / |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA040317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-09-30 |
| Marketing End Date | 2018-09-30 |